Amgen, Inc. (AMGN)
467.06
-1.05
(-0.22%)
USD |
NASDAQ |
Nov 12, 16:00
469.13
+2.07
(+0.44%)
After-Hours: 04:13
Amgen Price : 467.06 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 471.86 | 474.00 | 466.92 | 467.06 | 2.828M |
| Nov 11, 2026 | 460.98 | 468.46 | 459.14 | 468.11 | 2.006M |
| Nov 10, 2026 | 465.70 | 468.80 | 459.45 | 465.23 | 2.140M |
| Nov 09, 2026 | 465.14 | 466.54 | 454.46 | 465.23 | 2.311M |
| Nov 06, 2026 | 448.16 | 462.91 | 447.04 | 460.42 | 2.580M |
| Nov 05, 2026 | 483.99 | 483.99 | 459.65 | 460.28 | 4.107M |
| Nov 04, 2026 | 479.61 | 482.48 | 464.13 | 478.48 | 4.620M |
| Nov 03, 2026 | 463.38 | 467.04 | 460.15 | 461.26 | 2.382M |
| Nov 02, 2026 | 463.43 | 469.00 | 461.00 | 465.45 | 3.197M |
| Oct 30, 2026 | 470.15 | 475.64 | 465.33 | 466.01 | 3.291M |
| Oct 29, 2026 | 465.57 | 468.27 | 457.36 | 460.73 | 2.983M |
| Oct 28, 2026 | 441.03 | 454.66 | 439.57 | 451.83 | 2.912M |
| Oct 27, 2026 | 441.80 | 448.54 | 439.28 | 447.95 | 1.734M |
| Oct 26, 2026 | 444.89 | 449.80 | 439.50 | 444.63 | 2.053M |
| Oct 23, 2026 | 444.40 | 444.59 | 439.07 | 439.26 | 2.075M |
| Oct 22, 2026 | 441.55 | 450.98 | 437.19 | 447.28 | 3.105M |
| Oct 21, 2026 | 440.21 | 441.03 | 434.53 | 438.34 | 2.611M |
| Oct 20, 2026 | 425.58 | 439.05 | 425.11 | 438.94 | 2.217M |
| Oct 19, 2026 | 430.36 | 434.51 | 424.74 | 424.94 | 2.683M |
| Oct 16, 2026 | 437.89 | 438.82 | 431.39 | 432.49 | 2.567M |
| Oct 15, 2026 | 435.83 | 441.76 | 433.42 | 434.03 | 4.626M |
| Oct 14, 2026 | 417.83 | 428.05 | 415.20 | 426.11 | 3.085M |
| Oct 13, 2026 | 420.34 | 420.35 | 411.04 | 412.84 | 2.320M |
| Oct 12, 2026 | 416.12 | 417.76 | 413.44 | 417.57 | 1.721M |
| Oct 09, 2026 | 405.00 | 417.78 | 404.05 | 414.87 | 2.553M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 167.95 |
| Regeneron Pharmaceuticals, Inc. | 951.19 |
| AbbVie, Inc. | 294.45 |
| Biogen, Inc. | 250.48 |
| Vertex Pharmaceuticals, Inc. | 542.62 |
Price Related Metrics
| PE Ratio | 27.09 |
| PS Ratio | 6.522 |
| PEG Ratio | 0.8137 |
| Price to Book Value | 17.60 |
| Price to Free Cash Flow | 26.53 |
| Earnings Yield | 3.69% |
| Market Cap | 252.63B |
| PEGY Ratio | 0.7648 |
| Operating PE Ratio | 18.32 |
| Normalized PE Ratio | 24.86 |